Internalization of anti-nucleolin antibody into viable HEp-2 cells

Overview of attention for article published in Molecular Biology Reports, September 1996

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 61 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

HMGN2 peptides and related molecules that selectively home to tumor blood vessels and…

Grant US-9320810-B2

United States of America

HMGN2 peptides and related molecules that selectively home to tumor blood vessels and…

Grant US-8598112-B2

United States of America

HMGN2 peptides and related molecules that selectively home to tumor blood vessels and…

Grant US-8048983-B2

United States of America

Auxiliary method for diagnosis and therapy of cancer with nucleolin

Application EP-2375251-A1

European Patent Office

HMGN2 peptides and related molecules that selectively home to tumor blood vessels and…

Grant US-7544767-B2

United States of America

AUXILIARY METHOD FOR DIAGNOSIS AND THERAPY OF CANCER WITH NUCLEOLIN

Application WO-2006119706-A1

World Intellectual Property Organisation (WIPO)

Human nucleolin-like protein

Application US-6313266-B1

United States of America

Human nucleolin-like protein

Application US-5932475-A

United States of America